Literature DB >> 16502009

[Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil].

F Paul1, O Aktas, F-J Dieste, P Kreitsch, H-P Vogel, F Zipp.   

Abstract

We report a 37-year-old patient with gastric cancer who suffered two distinct episodes of generalized tonic-clonic seizures during ongoing chemotherapy with cisplatin and 5-fluorouracil. Cranial MRI revealed reversible posterior leukoencephalopathy (RPL) that remitted completely without any specific therapy after discontinuation of the chemotherapeutic drugs. Interestingly, RPL occurred repeatedly in our patient following the single chemotherapy cycles, which has not been described so far. This syndrome is clinically relevant for differential diagnosis of bilateral ischemia of the posterior cerebral arteries. An overview of the literature and necessary diagnostic procedures is given.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502009     DOI: 10.1007/s00115-006-2055-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  17 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.

Authors:  B Meglic; F Graus; A Grad
Journal:  J Neurol Sci       Date:  2001-04-01       Impact factor: 3.181

3.  Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus.

Authors:  I J Sutton; C J Fursdon Davis; M M Esiri; S Hughes; E R Amyes; A Vincent
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

4.  [Reversible bilateral cortical MRI changes as sequelae of status epilepticus].

Authors:  S Weidauer; K Krakow; H Lanfermann; F E Zanella
Journal:  Nervenarzt       Date:  2001-12       Impact factor: 1.214

Review 5.  [Paraneoplastic neurologic autoimmune diseases].

Authors:  R Voltz
Journal:  Nervenarzt       Date:  2002-10       Impact factor: 1.214

6.  Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.

Authors:  Y Ito; Y Arahata; Y Goto; M Hirayama; M Nagamutsu; T Yasuda; T Yanagi; G Sobue
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

Review 7.  Cisplatin-induced encephalopathy and seizures.

Authors:  N Steeghs; F E de Jongh; P A E Sillevis Smitt; M J van den Bent
Journal:  Anticancer Drugs       Date:  2003-07       Impact factor: 2.248

8.  [Neurooncology].

Authors:  M Weller
Journal:  Nervenarzt       Date:  2003-12       Impact factor: 1.214

Review 9.  Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide.

Authors:  Jörg Dietrich; Jörg Marienhagen; Berthold Schalke; Ulrich Bogdahn; Felix Schlachetzki
Journal:  Ann Pharmacother       Date:  2003-12-15       Impact factor: 3.154

10.  An interaction between cytostatic and anticonvulsant drugs.

Authors:  C Neef; I de Voogd-van der Straaten
Journal:  Clin Pharmacol Ther       Date:  1988-04       Impact factor: 6.875

View more
  3 in total

Review 1.  Reversible posterior leukoencephalopathy syndrome in cancer.

Authors:  Christopher Vaughn; Louann Zhang; David Schiff
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

2.  Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: A case report and literature review.

Authors:  Changqing Xie; Vovanti T Jones
Journal:  Oncol Lett       Date:  2015-12-24       Impact factor: 2.967

Review 3.  [Headache and hypertension. Myth and evidence].

Authors:  T Liman; E Siebert; M Endres
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.